# ValidEval V5 Venue-Ceiling Assessment

Date checked: 2026-07-15

The 2026 conference deadlines have passed. This assessment concerns a later cycle after the
required studies are executed; it is not a submission-readiness claim.

## Official-scope fit

- **NeurIPS Evaluations & Datasets:** the strongest aspirational fit. The 2026 call explicitly treats
  evaluation as a scientific object and welcomes rigorous audits, stress tests, evaluation
  protocols, negative results, and tools that improve how evaluative claims are interpreted
  ([official call](https://neurips.cc/Conferences/2026/CallForEvaluationsDatasets)). An audit using
  public data does not trigger new-dataset hosting/Croissant requirements, while executable-tool
  contributions require accessible documented code
  ([official FAQ](https://neurips.cc/Conferences/2026/EvaluationsDatasetsFAQ)).
- **NeurIPS main track:** `STRETCH`. The general criteria emphasize technical soundness, reproducibility,
  significance, and originality; negative-result and concept/feasibility submissions face a high
  significance/originality bar
  ([official reviewing guidelines](https://neurips.cc/Conferences/2026/ReviewerGuidelines)). A generic
  toolkit or single benchmark audit is insufficient.
- **TMLR:** a plausible eventual home for a careful analytical framework and multi-study empirical
  paper. TMLR explicitly accepts new assessment methods, analytical frameworks, and reproducibility
  studies, and asks whether claims have accurate, convincing evidence
  ([official editorial policy](https://jmlr.org/tmlr/editorial-policies.html)).
- **COLM:** a plausible language-model-specific conference fit because the 2026 scope includes
  benchmarks, evaluation protocols and metrics, and human/machine evaluation
  ([official call](https://colmweb.org/cfp.html)). It is less natural if the final contribution is
  framed as general measurement science beyond language models.

## Scenario A — Existing verified MMLU evidence only

- Strongest claim: a public HELM-derived 39-model MMLU response panel can support reproducible,
  protocol-scoped descriptions of subject-conditioned ranking variation and proxy item behavior.
- Fatal weakness: no controlled exact-model cross-benchmark evidence and no independent validation
  of the diagnostics; the legacy materiality threshold and ablation are not defensible.
- Current paper level: strong exploratory analysis / workshop-quality research artifact.
- Advisable venues now: workshop or non-archival feedback venue after further cleanup.
- Submission advisable now: no.
- Fit: `POSSIBLE_BUT_WEAK` for a full archival paper; `POOR_FIT` for NeurIPS main.

## Scenario B — Controlled MMLU + GSM8K

- Claims unlocked: exact-model two-construct ranking and interaction estimates under matched
  checkpoints/configuration, if overlap and extraction gates pass.
- Remaining weaknesses: two benchmarks are insufficient for broad transfer; human/external and
  confirmatory synthetic validation remain absent.
- Ceiling: `CREDIBLE` for COLM or TMLR if the result is clear and methods are strong;
  `POSSIBLE_BUT_WEAK` for NeurIPS E&D.

## Scenario C — Controlled MMLU + GSM8K + BBH

- Claims possible: limited exact-panel transfer, benchmark-specific specialization, and
  decision-stability findings with uncertainty.
- Required result pattern: informative heterogeneity or a rigorous negative result that changes
  how benchmark comparisons should be interpreted, not merely three correlation coefficients.
- Remaining gaps: independent diagnostic validation and human/external confirmation.
- Ceiling: `CREDIBLE` for NeurIPS E&D, TMLR, or COLM; NeurIPS main remains `STRETCH`.

## Scenario D — Three benchmarks + human/external validation

- Assumptions: adequate exact common panel, blinded human labels, confirmed external item identity,
  current baselines, robust uncertainty, and an executable anonymous release.
- Maximum credible target: `STRONG_FIT` for NeurIPS E&D if findings are scientifically important;
  `CREDIBLE` for TMLR/COLM; NeurIPS main is `STRETCH` unless the method or negative result is broadly
  novel and consequential.
- Required novelty: evidence that validating diagnostics changes conclusions, rankings, or repair
  decisions in a way not captured by existing benchmark checklists, IRT audits, or agreement tests.
- Major residual risks: panel representativeness, model-family dependence, benchmark contamination,
  human-label generalizability, and multiple/post-selected analyses.

## Current and maximum ceiling

- Current venue level: `STRONG EXPLORATORY / WORKSHOP-LEVEL ARTIFACT`.
- Highest credible ceiling after strong required evidence: `NEURIPS E&D STRONG_FIT`.
- Highest credible main-track label: `STRETCH`, conditional on a general method or surprising,
  rigorously demonstrated result.

No acceptance probability is estimated.
